Skip to main content
Erschienen in: Diabetologia 11/2016

18.08.2016 | Article

The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5

verfasst von: Qianghua Xia, Alessandra Chesi, Elisabetta Manduchi, Brian T. Johnston, Sumei Lu, Michelle E. Leonard, Ursula W. Parlin, Eric F. Rappaport, Peng Huang, Andrew D. Wells, Gerd A. Blobel, Matthew E. Johnson, Struan F. A. Grant

Erschienen in: Diabetologia | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

One of the most strongly associated type 2 diabetes loci reported to date resides within the TCF7L2 gene. Previous studies point to the T allele of rs7903146 in intron 3 as the causal variant at this locus. We aimed to identify the actual gene(s) under the influence of this variant.

Methods

Using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein-9 nuclease, we generated a 1.4 kb deletion of the genomic region harbouring rs7903146 in the HCT116 cell line, followed by global gene expression analysis. We then carried out a combination of circularised chromosome conformation capture (4C) and Capture C in cell lines, HCT116 and NCM460 in order to ascertain which promoters of these perturbed genes made consistent physical contact with this genomic region.

Results

We observed 99 genes with significant differential expression (false discovery rate [FDR] cut-off:10%) and an effect size of at least twofold. The subsequent promoter contact analyses revealed just one gene, ACSL5, which resides in the same topologically associating domain as TCF7L2. The generation of additional, smaller deletions (66 bp and 104 bp) comprising rs7903146 showed consistently reduced ACSL5 mRNA levels across all three deletions of up to 30-fold, with commensurate loss of acyl-CoA synthetase long-chain family member 5 (ACSL5) protein. Notably, the deletion of this single-nucleotide polymorphism region abolished significantly detectable chromatin contacts with the ACSL5 promoter. We went on to confirm that contacts between rs7903146 and the ACSL5 promoter regions were conserved in human colon tissue. ACSL5 encodes ACSL5, an enzyme with known roles in fatty acid metabolism.

Conclusions/interpretation

This ‘variant to gene mapping’ effort implicates the genomic location harbouring rs7903146 as a regulatory region for ACSL5.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Smemo S, Tena JJ, Kim KH et al (2014) Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371–375CrossRefPubMedPubMedCentral Smemo S, Tena JJ, Kim KH et al (2014) Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371–375CrossRefPubMedPubMedCentral
2.
3.
Zurück zum Zitat Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323CrossRefPubMed Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323CrossRefPubMed
4.
Zurück zum Zitat DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–244CrossRef DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–244CrossRef
5.
Zurück zum Zitat Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163CrossRefPubMedPubMedCentral Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Boj SF, van Es JH, Huch M et al (2012) Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151:1595–1607CrossRefPubMed Boj SF, van Es JH, Huch M et al (2012) Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151:1595–1607CrossRefPubMed
7.
Zurück zum Zitat Kaminska D, Kuulasmaa T, Venesmaa S et al (2012) Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism. Diabetes 61:2807–2813CrossRefPubMedPubMedCentral Kaminska D, Kuulasmaa T, Venesmaa S et al (2012) Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism. Diabetes 61:2807–2813CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Yi F, Brubaker PL, Jin T (2005) TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280:1457–1464CrossRefPubMed Yi F, Brubaker PL, Jin T (2005) TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280:1457–1464CrossRefPubMed
9.
Zurück zum Zitat Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R (2000) The human T cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 60:3872–3879PubMed Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R (2000) The human T cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 60:3872–3879PubMed
10.
Zurück zum Zitat Korinek V, Barker N, Moerer P et al (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379–383CrossRefPubMed Korinek V, Barker N, Moerer P et al (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379–383CrossRefPubMed
11.
Zurück zum Zitat Helgason A, Palsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225CrossRefPubMed Helgason A, Palsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225CrossRefPubMed
12.
Zurück zum Zitat Palmer ND, Hester JM, An SS et al (2011) Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 60:662–668CrossRefPubMedPubMedCentral Palmer ND, Hester JM, An SS et al (2011) Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 60:662–668CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Wellcome Trust Case Control C, Maller JB, McVean G et al (2012) Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet 44:1294–1301CrossRef Wellcome Trust Case Control C, Maller JB, McVean G et al (2012) Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet 44:1294–1301CrossRef
15.
Zurück zum Zitat Hughes JR, Roberts N, McGowan S et al (2014) Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet 46:205–212CrossRefPubMed Hughes JR, Roberts N, McGowan S et al (2014) Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet 46:205–212CrossRefPubMed
16.
Zurück zum Zitat van de Werken HJ, Landan G, Holwerda SJ et al (2012) Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat Methods 9:969–972CrossRefPubMed van de Werken HJ, Landan G, Holwerda SJ et al (2012) Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat Methods 9:969–972CrossRefPubMed
18.
Zurück zum Zitat Xia Q, Deliard S, Yuan CX, Johnson ME, Grant SF (2015) Characterization of the transcriptional machinery bound across the widely presumed type 2 diabetes causal variant, rs7903146, within TCF7L2. Eur J Hum Genet 23:103–109CrossRefPubMed Xia Q, Deliard S, Yuan CX, Johnson ME, Grant SF (2015) Characterization of the transcriptional machinery bound across the widely presumed type 2 diabetes causal variant, rs7903146, within TCF7L2. Eur J Hum Genet 23:103–109CrossRefPubMed
20.
Zurück zum Zitat Savic D, Ye H, Aneas I, Park SY, Bell GI, Nobrega MA (2011) Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res 21:1417–1425CrossRefPubMedPubMedCentral Savic D, Ye H, Aneas I, Park SY, Bell GI, Nobrega MA (2011) Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res 21:1417–1425CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Meller N, Morgan ME, Wong WP, Altemus JB, Sehayek E (2013) Targeting of Acyl-CoA synthetase 5 decreases jejunal fatty acid activation with no effect on dietary long-chain fatty acid absorption. Lipids Health Dis 12:88CrossRefPubMedPubMedCentral Meller N, Morgan ME, Wong WP, Altemus JB, Sehayek E (2013) Targeting of Acyl-CoA synthetase 5 decreases jejunal fatty acid activation with no effect on dietary long-chain fatty acid absorption. Lipids Health Dis 12:88CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Bowman T, O’Keeffe K, D’Aquila T et al (2016) CoA synthetase 5 (ACSL5) Ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption. Mol Metab 5:210–220CrossRefPubMedPubMedCentral Bowman T, O’Keeffe K, D’Aquila T et al (2016) CoA synthetase 5 (ACSL5) Ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption. Mol Metab 5:210–220CrossRefPubMedPubMedCentral
Metadaten
Titel
The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5
verfasst von
Qianghua Xia
Alessandra Chesi
Elisabetta Manduchi
Brian T. Johnston
Sumei Lu
Michelle E. Leonard
Ursula W. Parlin
Eric F. Rappaport
Peng Huang
Andrew D. Wells
Gerd A. Blobel
Matthew E. Johnson
Struan F. A. Grant
Publikationsdatum
18.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 11/2016
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4077-2

Weitere Artikel der Ausgabe 11/2016

Diabetologia 11/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.